Behavioral, biochemical, and pharmacological effects of chronic dosage of phenothiazine tranquilizers in rats.
D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects*; D001835:Body Weight / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects; D002746:Chlorpromazine / Q000008:administration & dosage / Q000009:adverse effects / Q000032:analysis / Q000097:blood / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005106:Exploratory Behavior / Q000187:drug effects; D066298:In Vitro Techniques; D007279:Injections, Subcutaneous; D008099:Liver / Q000032:analysis; D008112:Liver Glycogen / Q000032:analysis; D008297:Male; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D011395:Promazine / Q000008:administration & dosage / Q000009:adverse effects / Q000032:analysis / Q000097:blood / Q000494:pharmacology*; D013997:Time Factors; D014273:Triflupromazine / Q000008:administration & dosage / Q000009:adverse effects / Q000032:analysis / Q000097:blood / Q000494:pharmacology*; D014280:Triglycerides / Q000032:analysis
D008112:Liver Glycogen; D014280:Triglycerides; D011395:Promazine; D014273:Triflupromazine; D002746:Chlorpromazine